Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

RxSight, Inc. (RXST) Stock Forecast 2025 - AI Price Prediction & Analysis

RxSight, Inc. (RXST) AI Stock Price Forecast & Investment Analysis

RxSight, Inc. Stock Price Chart and Technical Analysis

Loading RxSight, Inc. interactive price chart and technical analysis...

RxSight, Inc. (RXST) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

RxSight, Inc. (Stock Symbol: RXST) is a leading company in the Industrial Applications and Services sector , specifically operating within the Ophthalmic Goods industry. The organization employs approximately 267 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $147 million generating a -212.0% net profit margin .

Market Capitalization: $364 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -9.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for RxSight, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

RxSight, Inc. strategically competes in the highly dynamic Ophthalmic Goods marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company maintains a healthy 25.5% gross margin, indicating strong pricing power and operational efficiency.

RxSight, Inc. (RXST) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for RxSight, Inc. stock analysis.

Loading RxSight, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into RxSight, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if RxSight, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For RxSight, Inc.: With a P/E ratio of -39.76, the market sees the stock as potentially undervalued.

P/E Ratio -39.76x
P/B Ratio 1.31x
Market Cap $364M
EPS $-0.80
Book Value/Share $6.80
Revenue/Share $3.59
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently RxSight, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For RxSight, Inc.: An ROE of -9.7% indicates room for improvement in shareholder value creation.

ROE -9.7%
ROA -43.5%
ROIC -6.4%
Gross Margin 25.5%
Operating Margin -207.6%
Net Margin -212.0%
EBT Margin -212.0%
Tax Rate 0.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess RxSight, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For RxSight, Inc.: A current ratio of 15.12 indicates strong liquidity.

Current Ratio 15.12x
Quick Ratio 14.02x
D/E Ratio 0.35x
Financial Leverage 1.44x
Interest Coverage -13.7x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal RxSight, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For RxSight, Inc.: Free cash flow of $-51M indicates cash challenges that need attention.

Operating Cash Flow $-49M
Free Cash Flow $-51M
Capital Spending $-2M
FCF/Sales -182.7%
CapEx/Sales 6.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively RxSight, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For RxSight, Inc.: An asset turnover of 0.21x suggests room for improvement in asset utilization.

Asset Turnover 0.21x
Receivables Turnover 7.1x
Inventory Turnover 2.3x
Fixed Assets Turnover 1.7x
Days Sales Outstanding 51 days
Days Inventory 159 days
Payables Period 39 days
Cash Conversion Cycle 172 days
Understanding Financial Statement Data

What these metrics mean: Key figures from RxSight, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For RxSight, Inc.: With annual revenue of $147M, RxSight, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $147M
R&D Expense $33M
SG&A Expense $146M
Cost of Goods Sold $40M
Balance Sheet Highlights ($ Millions)
Total Current Assets $91M
Cash & Short-term Investments $81M
Total Liabilities $30M
Accounts Receivable $3M
Inventory $5M
Dividend & Shareholder Information
Shares Outstanding 41M
Growth Metrics (YoY)
EPS Growth -2.7%

Latest RxSight, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting RxSight, Inc. (RXST) stock price and investment outlook.

, source: Yahoo Finance

RxSight Inc (NASDAQ:RXST) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for Q4 2024 revenue is $40.32 million, and the earnings are expected to come in at -$0.17 ...

RxSight, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of RxSight, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALC Unlock Forecast $24380M 11.0x x
BLCO Unlock Forecast $5367M -15.1x 0.8x
COO Unlock Forecast $13659M 33.5x 1.6x
EYE Unlock Forecast $1870M -14.0x 2.2x
LUCY Unlock Forecast $9M -2.4x 0.8x
LUCYW Unlock Forecast $0M x 0.0x
RXST Unlock Forecast $364M -39.8x 1.3x
STAA Unlock Forecast $1384M 68.0x 4.1x
WRBY Unlock Forecast $3271M -68.7x 9.1x

Frequently Asked Questions - RxSight, Inc. Stock Forecast

How accurate are RxSight, Inc. stock predictions?

Our AI model demonstrates 66% historical accuracy for RXST predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence RxSight, Inc. stock price forecasts?

Our analysis considers RxSight, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is RxSight, Inc. a good investment in 2025?

Based on our AI analysis, RxSight, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are RxSight, Inc. forecasts updated?

RxSight, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced RxSight, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for RxSight, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...